Gayle A. Crowell
Director · PLIANT THERAPEUTICS, INC.
- 2024
- Jun 12, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gayle A. Crowell files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Thomas J. Fallon - $856K in HTGC purchases and sales in the last 12 months
- Scott Bluestein - $553K in HTGC purchases and sales in the last 12 months
- Seth H. Meyer - $301K in HTGC purchases and sales in the last 12 months
- Nikos Theodosopoulos - $240K in HTGC purchases and sales in the last 12 months
- Robert P. Badavas - $199K in HTGC purchases and sales in the last 12 months
- Wade Loo - $154K in HTGC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gayle A. Crowell?
Gayle A. Crowell is a corporate insider, tracked as Director of PLIANT THERAPEUTICS, INC. (PLRX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Gayle A. Crowell last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 7 filings going back to 2024.
Has Gayle A. Crowell been buying or selling stock?
Recorded transactions: 4 open-market purchases ($417K) and 0 open-market sales across all tracked filings.
